Find publications by Adaptive as well as our collaborators and partners who leverage our technologies.




Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine

Rumfield et al.

  • Journal for ImmunoTherapy of Cancer
  • June 2020

Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors

Albershardt et al.

  • June 2020

Phase II Trial of IL-12 Plasmid Transfection and PD-1 Blockade in Immunologically Quiescent Melanoma

Algazi et al.

  • Clinical Cancer Research
  • June 2020

A circulating T-cell differentiation marker to predict response to immune checkpoint inhibitors

Yamauchi et al.

  • bioRxiv
  • June 2020

Immunotyping of clinically divergent p.Phe508del homozygous monozygous cystic fibrosis twins

Schamschula et al.

  • Journal of Cystic Fibrosis
  • June 2020

Immunotherapy of CT26 Murine Tumors Is Characterized by an Oligoclonal Response of Tissue-Resident Memory T Cells Against the AH1 Rejection Antigen

Stringhini et al.

  • European Journal of Immunology
  • May 2020

Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab

Casneuf et al.

  • Leukemia
  • May 2020

T Cell Clonal Dynamics Determined by High-Resolution TCR-β Sequencing in Recipients after Allogeneic Hematopoietic Cell Transplantation

Leick et al.

  • Biology of Blood and Marrow Transplantation
  • May 2020

Somatic mTOR Mutation in Clonally Expanded T Lymphocytes Associated With Chronic Graft Versus Host Disease

Kim et al.

  • Nature Communications
  • May 2020